TVM Life Science Ventures backs Esperas Pharma
TVM Life Science Ventures and Fonds de solidarité FTQ have made an investment in Esperas Pharma, a Montreal-based biopharmaceutical company focused on triple negative breast cancer. No financial terms were disclosed.
14 April 2015•5 mins read
